Archived Facts

Here’s how French pharmaceutical giant Sanofi-Aventis SA, which has initiated a hostile takeover attempt for Genzyme Corp. of Cambridge, Mass., describes how the proposed $18.5 billion deal would benefit the two companies and their shareholders:

See the original post here:
How Sanofi sees benefits of Genzyme takeover

Popular Posts:

Related Posts:

Leave a Reply